The United Laboratories International Holdings (HKG:3933) reported a 1.5% decline in profit attributable to owners to 2.66 billion yuan for 2024 from 2.70 billion yuan in the previous year, according to a filing with the Hong Kong bourse on Monday.
Basic earnings per share were 1.4639 yuan, a 1.5% decrease from 1.4867 yuan a year ago.
Revenue increased marginally to 13.76 billion yuan from 13.74 billion yuan in the prior year.
The board recommended a final dividend of 0.28 yuan per share and a special dividend of 0.12 yuan per share. Both dividends are subject to shareholders' approval in an upcoming annual general meeting.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.